Crinetics Pharmaceuticals (CRNX) Financial Statements
Price: $30.42
Market Cap: $2.83B
Avg Volume: 1.03M
Market Cap: $2.83B
Avg Volume: 1.03M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Crinetics Pharmaceuticals.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04M | $4.01M | $4.74M | $1.08M | $71.00K | $1.19M | $2.43M | $2.04M | $589.00K |
| Cost of Revenue | $- | $- | $1.39M | $1.26M | $57.00M | $1.11M | $24.48M | $9.23M | $5.10M |
| Gross Profit | $1.04M | $4.01M | $3.35M | $-184.00K | $-56.93M | $80.00K | $-22.05M | $-7.19M | $-4.51M |
| Gross Profit Ratio | 100.00% | 100.00% | 70.68% | -17.07% | -80178.87% | 6.71% | -908.20% | -351.49% | -765.87% |
| Research and Development Expenses | $240.16M | $168.53M | $130.22M | $84.25M | $57.00M | $41.51M | $24.48M | $9.23M | $5.10M |
| General and Administrative Expenses | $99.74M | $58.09M | $42.39M | $24.52M | $18.03M | $13.52M | $6.66M | $1.94M | $1.53M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $99.74M | $58.09M | $42.39M | $24.52M | $18.03M | $13.52M | $6.66M | $1.94M | $1.53M |
| Other Expenses | $- | $- | $4.97M | $61.00K | $-71.00K | $-1.19M | $1.59M | $-48.00K | $-1.00K |
| Operating Expenses | $339.89M | $226.62M | $172.62M | $108.78M | $74.95M | $53.83M | $28.71M | $9.13M | $6.04M |
| Cost and Expenses | $339.89M | $226.62M | $172.62M | $108.78M | $74.95M | $53.83M | $28.71M | $9.13M | $6.04M |
| Interest Income | $41.44M | $13.44M | $4.32M | $157.00K | $991.00K | $3.46M | $1.75M | $26.00K | $37.00K |
| Interest Expense | $- | $- | $4.32M | $- | $- | $- | $- | $8.00K | $11.00K |
| Depreciation and Amortization | $- | $1.10M | $1.39M | $1.26M | $1.23M | $1.11M | $471.00K | $128.00K | $92.00K |
| EBITDA | $-338.85M | $-221.51M | $-166.90M | $-106.78M | $-72.59M | $-49.31M | $-28.24M | $-9.00M | $-5.95M |
| EBITDA Ratio | -32613.47% | -5519.81% | -3523.31% | -9905.38% | -102233.80% | -4133.19% | -1163.06% | -440.05% | -1010.53% |
| Operating Income | $-338.85M | $-222.61M | $-167.88M | $-107.70M | $-74.95M | $-53.83M | $-28.71M | $-9.13M | $-6.04M |
| Operating Income Ratio | -32613.47% | -5547.17% | -3544.06% | -9990.91% | -105567.61% | -4512.32% | -1182.45% | -446.31% | -1026.15% |
| Total Other Income Expenses Net | $40.45M | $8.08M | $3.96M | $61.00K | $1.14M | $3.41M | $1.59M | $-30.00K | $25.00K |
| Income Before Tax | $-298.41M | $-214.53M | $-163.92M | $-107.64M | $-73.81M | $-50.42M | $-27.11M | $-9.16M | $-6.02M |
| Income Before Tax Ratio | -28720.69% | -5345.85% | -3460.38% | -9985.25% | -103960.56% | -4226.49% | -1116.76% | -447.78% | -1021.90% |
| Income Tax Expense | $- | $- | $-3.96M | $-922.00K | $-948.00K | $-887.00K | $1.59M | $-40.00K | $10.00K |
| Net Income | $-298.41M | $-214.53M | $-159.95M | $-106.72M | $-72.86M | $-49.53M | $-27.11M | $-9.16M | $-6.02M |
| Net Income Ratio | -28720.69% | -5345.85% | -3376.69% | -9899.72% | -102625.35% | -4152.14% | -1116.76% | -447.78% | -1021.90% |
| EPS | $-3.69 | $-3.69 | $-3.08 | $-2.78 | $-2.39 | $-2.05 | $-2.23 | $-0.66 | $-0.43 |
| EPS Diluted | $-3.69 | $-3.69 | $-3.08 | $-2.78 | $-2.39 | $-2.05 | $-2.23 | $-0.66 | $-0.43 |
| Weighted Average Shares Outstanding | 80.78M | 58.07M | 51.98M | 38.44M | 30.45M | 24.18M | 12.14M | 13.88M | 13.88M |
| Weighted Average Shares Outstanding Diluted | 80.78M | 58.07M | 51.98M | 38.44M | 30.45M | 24.18M | 12.14M | 13.88M | 13.88M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $264.55M | $54.90M | $32.67M | $200.69M | $93.09M | $40.33M | $44.97M | $14.19M | $12.15M |
| Short Term Investments | $1.09B | $503.66M | $301.75M | $133.01M | $77.79M | $78.07M | $118.90M | $- | $- |
| Cash and Short Term Investments | $1.35B | $558.55M | $334.43M | $333.71M | $170.88M | $118.39M | $163.88M | $14.19M | $12.15M |
| Net Receivables | $- | $9.35M | $- | $2.03M | $1.83M | $- | $- | $734.00K | $72.00K |
| Inventory | $- | $- | $- | $8.07M | $-1.83M | $-1.38M | $- | $141.00K | $98.00K |
| Other Current Assets | $21.32M | $6.25M | $10.76M | $8.07M | $4.78M | $1.32M | $876.00K | $239.00K | $43.00K |
| Total Current Assets | $1.38B | $574.15M | $345.18M | $344.72M | $177.49M | $123.34M | $166.68M | $15.16M | $12.37M |
| Property Plant Equipment Net | $55.58M | $57.43M | $4.99M | $4.72M | $5.41M | $6.46M | $4.23M | $400.00K | $224.00K |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $1.77M | $1.97M | $1.01M | $500.00K | $500.00K | $500.00K | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $3.63M | $2.00M | $37.00K | $568.00K | $40.00K | $82.00K | $- | $33.00K | $10.00K |
| Total Non-Current Assets | $59.20M | $61.20M | $6.99M | $6.29M | $5.95M | $7.04M | $4.73M | $433.00K | $234.00K |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $1.43B | $635.35M | $352.18M | $351.01M | $183.44M | $130.38M | $171.41M | $15.60M | $12.60M |
| Account Payables | $5.85M | $6.55M | $6.88M | $3.42M | $3.49M | $2.70M | $1.46M | $403.00K | $340.00K |
| Short Term Debt | $7.15M | $4.17M | $1.05M | $- | $- | $- | $- | $- | $49.00K |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $2.18M | $2.06M | $2.24M | $-939.00K | $-835.00K | $-724.00K | $- | $- | $- |
| Other Current Liabilities | $44.50M | $31.16M | $17.55M | $12.57M | $7.00M | $5.64M | $6.47M | $494.00K | $501.00K |
| Total Current Liabilities | $59.68M | $43.94M | $27.72M | $15.99M | $10.49M | $8.34M | $7.92M | $897.00K | $890.00K |
| Long Term Debt | $44.57M | $47.55M | $2.02M | $3.07M | $4.01M | $4.85M | $- | $- | $163.00K |
| Deferred Revenue Non-Current | $- | $4.75M | $6.10M | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $-6.10M | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $5.53M | $- | $- | $2.00K | $23.00K | $49.00K | $3.27M | $29.72M | $17.75M |
| Total Non-Current Liabilities | $50.10M | $52.30M | $8.12M | $3.08M | $4.04M | $4.90M | $3.27M | $29.72M | $17.91M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $109.79M | $96.25M | $35.85M | $19.07M | $14.53M | $13.24M | $11.19M | $30.62M | $18.80M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $171.41M | $29.70M | $17.74M |
| Common Stock | $2.28B | $1.19B | $759.43M | $607.58M | $336.51M | $210.79M | $24.00K | $1.00K | $1.00K |
| Retained Earnings | $-952.11M | $-653.70M | $-439.17M | $-275.25M | $-167.61M | $-93.80M | $-43.38M | $-16.27M | $-7.11M |
| Accumulated Other Comprehensive Income Loss | $963.00K | $977.00K | $-3.93M | $-382.00K | $25.00K | $148.00K | $61.00K | $-304.00K | $-182.00K |
| Other Total Stockholders Equity | $- | $- | $- | $- | $- | $- | $-342.83M | $1.55M | $1.08M |
| Total Stockholders Equity | $1.32B | $539.11M | $-439.17M | $-275.25M | $-167.61M | $-93.80M | $-43.38M | $-15.02M | $-6.20M |
| Total Equity | $1.32B | $539.11M | $-439.17M | $-275.25M | $-167.61M | $-93.80M | $-43.38M | $-15.02M | $-6.20M |
| Total Liabilities and Stockholders Equity | $1.43B | $635.35M | $-403.32M | $-256.18M | $-153.09M | $-80.56M | $-32.19M | $15.60M | $12.60M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $1.43B | $635.35M | $-403.32M | $-256.18M | $-153.09M | $-80.56M | $-32.19M | $15.60M | $12.60M |
| Total Investments | $1.09B | $505.43M | $301.75M | $134.02M | $77.79M | $78.07M | $118.90M | $- | $- |
| Total Debt | $51.72M | $51.73M | $2.02M | $3.07M | $4.01M | $4.85M | $- | $- | $212.00K |
| Net Debt | $-212.82M | $-3.17M | $-30.65M | $-197.62M | $-89.07M | $-35.48M | $-44.97M | $-14.19M | $-11.94M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-298.41M | $-214.53M | $-163.92M | $-107.64M | $-73.81M | $-50.42M | $-27.11M | $-9.16M | $-6.02M |
| Depreciation and Amortization | $2.79M | $1.10M | $983.00K | $922.00K | $948.00K | $887.00K | $471.00K | $128.00K | $92.00K |
| Deferred Income Tax | $- | $-28.48M | $- | $422.00K | $-227.00K | $-1.23M | $- | $- | $- |
| Stock Based Compensation | $69.39M | $40.94M | $28.27M | $17.35M | $10.43M | $6.29M | $2.32M | $271.00K | $270.00K |
| Change in Working Capital | $11.63M | $8.04M | $18.61M | $1.10M | $376.00K | $-2.13M | $5.30M | $-721.00K | $189.00K |
| Accounts Receivables | $17.54M | $14.65M | $10.99M | $6.29M | $2.72M | $- | $- | $- | $- |
| Inventory | $- | $- | $- | $-6.29M | $-2.72M | $- | $- | $- | $- |
| Accounts Payables | $- | $- | $10.99M | $6.29M | $2.72M | $696.00K | $7.36M | $47.00K | $300.00K |
| Other Working Capital | $-5.91M | $-6.60M | $-3.38M | $-5.20M | $-2.35M | $-2.83M | $-2.06M | $-768.00K | $-111.00K |
| Other Non Cash Items | $-11.37M | $26.63M | $850.00K | $-739.00K | $261.00K | $222.00K | $-433.00K | $480.00K | $154.00K |
| Net Cash Provided by Operating Activities | $-225.97M | $-166.31M | $-115.20M | $-88.59M | $-62.03M | $-46.38M | $-19.46M | $-9.48M | $-5.47M |
| Investments in Property Plant and Equipment | $-3.84M | $-4.69M | $-1.66M | $-436.00K | $-186.00K | $-492.00K | $-1.06M | $-304.00K | $-190.00K |
| Acquisitions Net | $- | $195.72M | $34.00K | $422.00K | $-227.00K | $-1.23M | $- | $- | $- |
| Purchases of Investments | $-1.16B | $-532.86M | $-329.82M | $-125.40M | $-135.59M | $-108.14M | $-118.40M | $- | $- |
| Sales Maturities of Investments | $575.80M | $337.13M | $157.49M | $69.36M | $136.00M | $150.29M | $- | $- | $- |
| Other Investing Activities | $14.93M | $-195.72M | $-34.00K | $-422.00K | $227.00K | $1.23M | $-118.40M | $- | $- |
| Net Cash Used for Investing Activities | $-574.82M | $-200.41M | $-173.98M | $-56.48M | $217.00K | $41.67M | $-119.46M | $-304.00K | $-190.00K |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $-212.00K | $-48.00K |
| Common Stock Issued | $970.05M | $369.02M | $117.24M | $249.54M | $114.28M | $- | $106.47M | $12.04M | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $-59.00K | $- | $- | $-5.00K |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $40.39M | $19.93M | $4.72M | $3.14M | $288.00K | $126.00K | $63.73M | $12.04M | $-10.00K |
| Net Cash Used Provided by Financing Activities | $1.01B | $388.94M | $121.96M | $252.68M | $114.57M | $67.00K | $170.20M | $11.82M | $-53.00K |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $209.65M | $22.22M | $-167.22M | $107.61M | $52.76M | $-4.65M | $31.28M | $2.04M | $-5.71M |
| Cash at End of Period | $265.85M | $56.20M | $33.97M | $201.19M | $93.59M | $40.83M | $45.47M | $14.19M | $12.15M |
| Cash at Beginning of Period | $56.20M | $33.97M | $201.19M | $93.59M | $40.83M | $45.47M | $14.19M | $12.15M | $17.86M |
| Operating Cash Flow | $-225.97M | $-166.31M | $-115.20M | $-88.59M | $-62.03M | $-46.38M | $-19.46M | $-9.48M | $-5.47M |
| Capital Expenditure | $-3.84M | $-4.69M | $-1.66M | $-436.00K | $-186.00K | $-492.00K | $-1.06M | $-304.00K | $-190.00K |
| Free Cash Flow | $-229.81M | $-171.00M | $-116.86M | $-89.02M | $-62.21M | $-46.87M | $-20.52M | $-9.78M | $-5.66M |